|Last Price$79.80||Day Change (%)-1.08%|
|Open Price$80.45||Day Change ($)-0.87|
|Day Range79.73–81.18||52-Week Range55.95–83.36|
As of Fri 03/14/2014 03:39 PM EST | USD
Knowles Set to Join the S&P MidCap 400; 8x8, Universal Insurance to Join S&P SmallCap 600
On Monday, Neurocrine Biosciences NBIX accelerated its anticipated filing date for indiplon capsules to the second quarter of 2007 instead of 2009. We're placing Neurocrine under review while we revisit our assumptions, and because DOV Pharmaceutical DOVP is entitled to a royalty on any indiplon ...
Industrial activity remains slow and steady, giving companies a chance to navigate the environment.
We like 3-D printer firms' growth fundamentals, but current valuations limit long-term investor returns.
Widening investment-grade credit spreads and rising interest rates lead to losses.
A number of technical factors in the municipal bond market have magnified the selling pressure.